Induction of Minor Histocompatibility Antigen HA-1–Specific Cytotoxic T Cells for the Treatment of Leukemia After Allogeneic Stem Cell Transplantation
Open Access
- 15 December 1999
- journal article
- Published by American Society of Hematology in Blood
- Vol. 94 (12) , 4374-4376
- https://doi.org/10.1182/blood.v94.12.4374
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Tetrameric HLA class I–minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host diseaseNature Medicine, 1999
- Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine TherapiesBlood, 1999
- Feasibility of Immunotherapy of Relapsed Leukemia With Ex Vivo–Generated Cytotoxic T Lymphocytes Specific for Hematopoietic System-Restricted Minor Histocompatibility AntigensBlood, 1999
- Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In VivoThe Journal of Experimental Medicine, 1998
- The Minor Histocompatibility Antigen HA-1: A Diallelic Gene with a Single Amino Acid PolymorphismScience, 1998
- Mismatches of Minor Histocompatibility Antigens between HLA-Identical Donors and Recipients and the Development of Graft-Versus-Host Disease after Bone Marrow TransplantationNew England Journal of Medicine, 1996